Federal Health Officials Emphasize Workforce and Mission Fit in Technology Adoption

Federal health officials are urging agencies to balance the push to adopt artificial intelligence and other emerging technologies with practical mission needs. Speaking on Nov. 12 at the GDIT Emerge: Protect the Homeland event in Washington, D.C., Dr. Henry Walke of the Centers for Disease Control and Prevention (CDC) and Saum Ghosh of the Food and Drug Administration (FDA) cautioned against pursuing technology simply because it is new. Their comments came as the federal government seeks to accelerate technology adoption, including AI, to improve government operations and national security.

Walke, director of the CDC’s Office of Readiness and Response, said the agency is integrating new technologies into communications with state and local health departments about potential health emergencies. He stressed that technology investments should not displace investment in people: “But at the same time, we really need to continue to invest in our workforce.” His example of an emergency response underscored that critical signals may come not only from monitoring systems but also from direct communication: a clinician could call about a patient who traveled to Central Africa and has signs and symptoms of Ebola, prompting consultation and quick testing.

The remarks have practical implications for companies developing or selling AI, analytics, communications, and other technology to federal health agencies. Contractors should be prepared to show how their tools support the judgment and capabilities of agency personnel and frontline partners, rather than assuming automation alone will satisfy mission needs. Walke also emphasized that systems need to be integrated and agencies must communicate with partners, especially clinicians on the front lines. That points to interoperability, operational workflows, and partner-facing communications as important dimensions of solution fit.

Ghosh, director of the Immediate Office in the FDA’s Office of Mission IT Services, similarly said agencies should be “very careful about running after the next shiny object.” He acknowledged that tools, algorithms, and technologies can work well in particular situations, and that newer technologies can offer valuable speed. But he said officials need to be “extremely comfortable and confident” that deployed technology will meet the needs of the situation. The discussion is market direction, not an active procurement: no solicitation, award, or contract was announced. Vendors can use the stated priorities to shape demonstrations and future proposals by making mission suitability, reliability, integration, and human oversight explicit.

• CDC is integrating technology into communications with state and local health departments about potential health emergencies.
• Dr. Henry Walke, director of the CDC Office of Readiness and Response, emphasized continued investment in workforce capabilities alongside new tools.
• Walke described a possible Ebola response involving a clinician’s call, consultation, and quick testing, illustrating the continuing role of human communication and judgment.
• Walke said systems need to be integrated and agencies need to communicate with partners, particularly clinicians on the front lines.
• FDA official Saum Ghosh cautioned against adopting the “next shiny object” without confirming it fits the situation.
• Ghosh said technology may provide valuable speed, but agencies must be confident that deployed tools meet operational needs.
• The officials spoke on Nov. 12 at the GDIT Emerge: Protect the Homeland event in Washington, D.C.
• The comments came amid a federal push to accelerate AI and technology adoption; the source notes a June executive order calling for work with the private sector to modernize information systems and cultivate AI-enabled capabilities.
• No procurement action was announced. Contractors should treat the remarks as market guidance and demonstrate interoperability, workforce support, human oversight, and mission-specific performance in future engagements.